<DOC>
	<DOCNO>NCT00019110</DOCNO>
	<brief_summary>RATIONALE : Vaccines make certain human papillomaviruses may able help body kill tumor cell . PURPOSE : Phase II trial study effectiveness human papillomavirus vaccine therapy treat patient advanced recurrent cancer cervix , vagina , penis , anus , esophagus , head neck .</brief_summary>
	<brief_title>Vaccine Therapy Treating Patients With Advanced Recurrent Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether endogenous cellular immunity viral oncoproteins human papilloma virus 16 ( HPV16 ) E6 E7 present patient advance recurrent carcinoma cervix carcinoma carry HPV16 . - Determine whether vaccination antigen-presenting cell pulse synthetic peptide correspond tumor 's HPV16 E6 E7 peptide induce boost patient cellular immunity particular peptide . - Determine type characteristic cellular immunity generate patient treated regimen . - Determine toxicity regimen patient . - Determine tumor response patient treat regimen . - Determine whether vivo T cell generate specifically HPV16 E6 E7 peptide clone expanded vitro correspond peptide . OUTLINE : Patients stratify accord disease category define follow : - Stratum A : Stage III cervical cancer previously treat appropriate radiotherapy ; stage IV recurrent cervical cancer ; advanced tumor harbor human papilloma virus 16 ( HPV16 ) anogenital , esophageal , head neck cancer . - Stratum B : Stage III cervical cancer previously treat standard therapy evidence residual disease . Vaccination group give adjuvant therapy . Patients assign receive HPV E6 E7 peptide principal investigator . Peripheral blood mononuclear cell ( PBMC ) ( antigen present cell ) harvest treated vitro sargramostim ( GM-CSF ) pulse HPV16 E6 E7 . Patients receive vaccination HPV16 E6 E7 pulse PBMC IV 1-2 minute week 1 , 3 , 7 , 11 total 4 vaccination . Treatment continue absence disease progression unacceptable toxicity . Patients achieve complete response ( CR ) continue treatment maximum 1 year past CR . Patients follow 1 month . PROJECTED ACCRUAL : A total 40-46 patient ( least 28 patient stratum A 12 stratum B ) accrue study within 1-2 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Anus Neoplasms</mesh_term>
	<mesh_term>Penile Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven stage III , IV , recurrent carcinoma cervix tumor carry human papilloma virus 16 ( HPV16 ) anogenital ( vulvar , penile , anal ) , esophageal , head neck cancer HLAA2.1 positive Patients tumor cervical cancer must therapeutic option Fresh tissue paraffin block available HPV genome detection typing ( optional cervical cancer ) No history CNS metastases PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 01 Life expectancy : More 3 month Hematopoietic : WBC least 2,000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 2.0 mg/dL SGPT great 4 time normal Renal : Creatinine great 2.0 mg/dL Cardiovascular : No myocardial infarction within past 6 month No New York Heart Association class III IV heart disease Immunologic : No autoimmune disease , e.g . : Systemic lupus erythematosus Multiple sclerosis Ankylosing spondylitis HIV negative Responsive 1 follow skin test antigen : Mumps Trichophyton Candida Tetanus Other : No active infection require antibiotic No weight loss great 20 % within past 6 month No active malignancy except basal cell skin cancer Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior immunotherapy recover Chemotherapy : At least 4 week since prior chemotherapy recover Endocrine therapy : At least 4 week since prior steroid recover Radiotherapy : At least 4 week since prior radiotherapy recover Surgery : Not specify Other : Recovered toxic effect prior therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 1999</verification_date>
	<keyword>stage IV anal cancer</keyword>
	<keyword>recurrent anal cancer</keyword>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>stage IV esophageal cancer</keyword>
	<keyword>stage IIIA anal cancer</keyword>
	<keyword>stage IIIB anal cancer</keyword>
	<keyword>recurrent esophageal cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>stage IV cervical cancer</keyword>
	<keyword>recurrent cervical cancer</keyword>
	<keyword>stage III vulvar cancer</keyword>
	<keyword>stage IVB vulvar cancer</keyword>
	<keyword>recurrent vulvar cancer</keyword>
	<keyword>stage III penile cancer</keyword>
	<keyword>stage IV penile cancer</keyword>
	<keyword>recurrent penile cancer</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III basal cell carcinoma lip</keyword>
	<keyword>stage III verrucous carcinoma oral cavity</keyword>
	<keyword>stage III mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage III adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV basal cell carcinoma lip</keyword>
	<keyword>stage IV verrucous carcinoma oral cavity</keyword>
	<keyword>stage IV mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent basal cell carcinoma lip</keyword>
	<keyword>recurrent verrucous carcinoma oral cavity</keyword>
	<keyword>recurrent mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>recurrent adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III lymphoepithelioma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV lymphoepithelioma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent lymphoepithelioma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent lymphoepithelioma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III verrucous carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV verrucous carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent verrucous carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage III midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage III esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
</DOC>